-
Signature
-
/s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan
-
Stock symbol
-
G
-
Transactions as of
-
Feb 1, 2023
-
Transactions value $
-
-$4,203,805
-
Form type
-
4
-
Date filed
-
2/3/2023, 04:15 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
G |
Common Shares |
Options Exercise |
$968K |
+50K |
+8.03% |
$19.35 |
673K |
Feb 1, 2023 |
Direct |
|
transaction |
G |
Common Shares |
Sale |
-$2.37M |
-50K |
-7.43% |
$47.42 |
623K |
Feb 1, 2023 |
Direct |
F1 |
transaction |
G |
Common Shares |
Options Exercise |
$968K |
+50K |
+8.03% |
$19.35 |
673K |
Feb 2, 2023 |
Direct |
|
transaction |
G |
Common Shares |
Sale |
-$2.38M |
-50K |
-7.43% |
$47.60 |
623K |
Feb 2, 2023 |
Direct |
F2 |
transaction |
G |
Common Shares |
Options Exercise |
$968K |
+50K |
+8.03% |
$19.35 |
673K |
Feb 3, 2023 |
Direct |
|
transaction |
G |
Common Shares |
Sale |
-$2.36M |
-50K |
-7.43% |
$47.10 |
623K |
Feb 3, 2023 |
Direct |
F3 |
holding |
G |
Common Shares |
|
|
|
|
|
10K |
Feb 1, 2023 |
By Trust |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
G |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-50K |
-5.56% |
$0.00 |
850K |
Feb 1, 2023 |
Common Shares |
50K |
$19.35 |
Direct |
F5 |
transaction |
G |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-50K |
-5.88% |
$0.00 |
800K |
Feb 2, 2023 |
Common Shares |
50K |
$19.35 |
Direct |
F5 |
transaction |
G |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-50K |
-6.25% |
$0.00 |
750K |
Feb 3, 2023 |
Common Shares |
50K |
$19.35 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.